References
- Pepys M B. Amyloidosis. Oxford Textbook of Medicine, 3rd edn, D J Weatherall, J GG Ledingham, D A Warrel. Oxford University. 1995; 1512–1534
- Falk R H, Comenzo R L, Skinner M. The Systemic Amyloidoses. N Engl J Med 1997; 337: 898–908
- Gillmore J D. Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Haematol 1997; 99: 245–256
- Lolin Y I, Chow J, Wicham N. Monoclonal gammopathy of unknown significance and malignant para-proteinemia in Hong Kong. Am J Clin Pathol 1996; 106: 449–456
- Kyle R A. Monoclonal proteins and renal disease. Annu Rev Med 1994; 45: 71–77
- Kyle R A, Greipp P R. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58: 665–683
- Kyle R A, Gertz M A. Primary Systemic Amyloidosis: Clinical and Laboratory Features in 474 Cases. Semin Haematol 1995; 32: 45–59
- Ikeda S, Takabayashi Y, Maejima Y, Tachibana N, Ehara T, Nezu A, Hoshii Y. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis Amyloid. Int J Exp Clin Invest 1999; 6: 292–296
- Gertz M A, Kyle R A. Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 1994; 24: 124–138
- Kyle R A. Monoclonal gammopathy of undetermined significance. Am J Med 1978; 64: 814–826
- Kyle R A. Monoclonal gammopathy of undetermined significance (MGUS). Baillieres Clin Haematol 1995; 8: 761–781
- Ropper A H, Gorson K C. Neuropathies associated with paraproteins. N Engl J Med 1998; 338: 1601–1607
- Isobe T, Osserman E F. Pathologic conditions associated with plasma cell dyscrasia. A study of 806 cases. Ann NY Acad Sci 1971; 190: 507
- Ameis A, Ko H S, Pruzanski W. M components-a review of 1242 cases. CMA Journal 1976; 114: 889–895
- Peltonem S, Wasastjerna C, Wager O. Clinical features of patients with a serum M component. Acta Med Scan 1978; 203: 257–263
- Pick A I, Shoenfeld Y, Frohlichmann R, Weiss H, Vana D, Schreibman S. Plasma Cell Dyscrasia. Analysis of 423 Patients. JAMA 1979; 241: 2275–2278
- Kyle R A, Robinson R A, Katzmann J A. The clinical aspects of biclonal gammopathies. Am J Med 1981; 71: 999–1008
- Bouvet J P, Feingold J, Oriol R, Liacopoulos P. Statistical Study of double paraproteinemias. Evidence for a common celular origin of both myeloma globulins. Biomedi-cine 1975; 22: 517–523
- Nilsson T, Norberg B, Rudolphi O, Jacobson L. Double gammopathies: incidence an clinical course of 20 patients. Scand J Haematol 1986; 36: 103–106
- Presti B C, Sciotto C G, Marsh S G. Lymphocytic Lymphoma with Associated Gamma Haevy Chain and IgM-Lambda Paraproteins. Am J Clin Pathol 1990; 93: 137–141
- Julien J, Vital C, Vallat J M, Lagueny A, Ferrer X, Deminiere C, Leboutet M J, Effroy C. IgM Demyelinative Neuropathy with Amyloidosis and Biclonal Gammopathy. Ann Neurol 1984; 15: 395–399
- Bouvet J P, Delrieu F. Polyarteritis Nodosa Associated with Biclonal Gammopathy of Two-Cell Line Origin and Amyloidosis. J Rheumatol 1985; 12: 160–170
- Clausen J, Christensen H E. Paraproteins and acid mucopolysaccharides in primary amyloidosis: biochemical and histologic studies of four human cases of primary amyloidodis. Acta Pathol Microbiol Scand 1964; 60: 493–511